The filing is a routine insider intent-to-sell notice for shares acquired through vesting. The insider has a history of periodic sales, and the proposed amount is small. No material read-through for the stock.
Price Chart
Executive Summary
Soleil Boughton, an officer of Hims & Hers Health, Inc., filed a Form 144 notice of intent to sell 3,462 shares of Class A common stock, valued at approximately $95,551. The shares were acquired via restricted stock vesting on August 15, 2026. The filing also lists four prior sales by the same insider between August and October 2026 totaling approximately $1.07M, indicating a pattern of periodic selling.
Key Facts
- Insider Soleil Boughton (Officer) filed Form 144 to sell 3,462 shares of Class A common stock.
- Estimated value of proposed sale: $95,551.20 based on a market price of ~$27.60 per share.
- Shares were acquired via restricted stock vesting on August 15, 2026.
- The filing also discloses four prior sales by the same insider from August to October 2026 totaling 38,266 shares for approximately $1.07M.
- The proposed sale represents a small fraction of the company's $6.4B market cap (approximately 0.0015%).
Financial Impact
Proposed sale of $95,551 (3,462 shares) is immaterial relative to the $6.4B market cap; prior sales total ~$1.07M.
Risk Factors
- Form 144 signals intent to sell, but the sale may not be executed.
- Insider selling pattern (four prior sales in two months) could indicate ongoing diversification, but amounts are modest.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007514 |
| Document: 0001959173-26-007514-index.html | 0001959173-26-007514 |
| Document: 0001959173-26-007514.txt | 0001959173-26-007514 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | 144 | $29.32 | awaiting T+20 | awaiting T+20 | $29.67 (+1.19%) |
Oct 27, 2026 2d ago | Institutional Cluster | $27.92 | awaiting T+20 | awaiting T+20 | $29.67 (+6.27%) |
Oct 7, 2026 22d ago | 8-K | $28.06 | awaiting T+20 | awaiting T+20 | $29.67 (+5.74%) |
Sep 23, 2026 5w ago | Insider Cluster | $29.28 $29.13 | ▲ +0.51% | ▲ +0.09% | $29.67 (−1.33%) |
Sep 18, 2026 5w ago | Insider Cluster | $29.35 $28.15 | ▲ +4.09% | ▲ +3.18% | $29.67 (−1.09%) |
Sep 17, 2026 6w ago | Insider Cluster | $27.99 $28.07 | ▼ −0.29% | ▼ −0.08% | $29.67 (−6.00%) |
Aug 20, 2026 10w ago | Insider Cluster | $33.78 $29.35 | ▼ −13.11% | ▼ −14.13% | $29.67 (−12.17%) |
Aug 20, 2026 10w ago | Insider Cluster | $33.78 $29.35 | ▼ −13.11% | ▼ −14.13% | $29.67 (−12.17%) |
Aug 18, 2026 10w ago | Insider Cluster | $31.09 $27.89 | ▼ −10.29% | ▼ −9.45% | $29.67 (−4.57%) |
Aug 10, 2026 11w ago | 8-K | $30.51 $27.90 | ▼ −8.55% | ▼ −7.50% | $29.67 (−2.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers